Future Oncology, Volume 18, Issue 17 (2022)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Future Oncology, Volume 18, Issue 17 (2022)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Volume 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Clinical Trial Protocol

Review Article
STARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma
Dirk Schadendorf, Reinhard Dummer, Caroline Robert, Antoni Ribas, Ryan J Sullivan, Timothy Panella, Meredith McKean, Edgardo S Santos, Kimberli Brill, Anna Polli, Alessandra di Pietro & Paolo A Ascierto
Pages: 2041-2051
Published online: 11 Mar 2022
AbstractforSTARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 4678 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Short Communication

Brief Report
Phase I/Ib dose-escalation study of avelumab in Chinese patients with advanced solid tumors
Yi-Long Wu, Ying Cheng, Huajun Chen, Haiyan Tu, Chongrui Xu, Zhen Wang, Ying Liu, Ying Xin, Haizhou Lou, Wei Wang, Kevin Chin, Dandan Li, Di Zhao, Yanfei Gao, Wenping Xu & Hongming Pan
Pages: 2053-2062
Published online: 31 Mar 2022
AbstractforPhase I/Ib dose-escalation study of avelumab in Chinese patients with advanced solid tumors | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 1246 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Research Article

Article
Effectiveness of crizotinib versus entrectinib in ROS1-positive non-small-cell lung cancer using clinical and real-world data
Gabriel Tremblay, Michael Groff, Laura Iadeluca, Patrick Daniele, Keith Wilner, Robin Wiltshire, Lauren Bartolome, Tiziana Usari, Joseph C Cappelleri & D Ross Camidge
Pages: 2063-2074
Published online: 02 Mar 2022
AbstractforEffectiveness of crizotinib versus entrectinib in ROS1-positive non-small-cell lung cancer using clinical and real-world data | Full Text | References | PDF (1.6 MB) | EPUB
  • 5309 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Patient preferences for frontline therapies for Philadelphia chromosome-positive acute lymphoblastic leukemia: a discrete choice experiment
Ajibade Ashaye, Caitlin Thomas, Mehul Dalal, Vamsi Kota, Nicolas Krucien, Maria Sae-Hau, Elisa Weiss, Scott Campbell & Kevin Marsh
Pages: 2075-2085
Published online: 25 Feb 2022
AbstractforPatient preferences for frontline therapies for Philadelphia chromosome-positive acute lymphoblastic leukemia: a discrete choice experiment | Full Text | References | PDF (2.3 MB) | EPUB | Supplemental
  • 1525 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Real-world outcomes of systemic therapy in locally advanced, recurrent or metastatic cutaneous squamous cell carcinoma
Thao T Vo, Janet L Espirito, Marley Boyd, Burak Gumuscu, Diana Chirovsky, Nicholas J Robert, Ramona F Swaby, Wei Zhou & Charles Lance Cowey
Pages: 2087-2099
Published online: 04 Mar 2022
AbstractforReal-world outcomes of systemic therapy in locally advanced, recurrent or metastatic cutaneous squamous cell carcinoma | Full Text | References | PDF (1.6 MB) | EPUB
  • 313 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Real-world treatment patterns of palbociclib and blood count monitoring in patients with advanced breast cancer in Japan
Masataka Sawaki, Yasuaki Muramatsu, Kanae Togo, Thomas Laurent & Hiroji Iwata
Pages: 2101-2111
Published online: 21 Mar 2022
AbstractforReal-world treatment patterns of palbociclib and blood count monitoring in patients with advanced breast cancer in Japan | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 2554 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Outcomes of postoperative adjuvant transarterial chemoembolization for hepatocellular carcinoma according to the Ki67 index
Jing-Xuan Xu, Wan-Ting Xing, Yu-Chong Peng, Yuan-Yuan Chen & Lu-Nan Qi
Pages: 2113-2125
Published online: 10 Mar 2022
AbstractforOutcomes of postoperative adjuvant transarterial chemoembolization for hepatocellular carcinoma according to the Ki67 index | Full Text | References | PDF (2.6 MB) | EPUB | Supplemental
  • 121 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Clinical and genetic predictions of early-onset cardiac toxicity in adjuvant chemotherapy for breast cancer
Binliang Liu, Xiuwen Guan, Yanfeng Wang, Xiaoying Sun, Zongbi Yi, Dan Lv, Wenna Wang, Lixi Li, Jingtong Zhai, Hong Li & Fei Ma
Pages: 2127-2139
Published online: 13 Apr 2022
AbstractforClinical and genetic predictions of early-onset cardiac toxicity in adjuvant chemotherapy for breast cancer | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 141 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Bibliometric analysis of N6-methyladenosine in cancer: landscapes, highlights and trending topics
Haotian Jiang, Yuan Li, Yinghui Liu & Weiguo Dong
Pages: 2141-2153
Published online: 05 Apr 2022
AbstractforBibliometric analysis of N6-methyladenosine in cancer: landscapes, highlights and trending topics | Full Text | References | PDF (16.6 MB) | EPUB
  • 2129 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Meta-Analysis

Article
Systematic literature review and network meta-analysis of pembrolizumab versus other interventions for previously untreated, unresectable or metastatic, MSI-high or MMR-deficient CRC
He Jin, Mayur Amonkar, Raquel Aguiar-Ibáñez, Manasi Thosar, Monica Chase & Sam Keeping
Pages: 2155-2171
Published online: 25 Mar 2022
AbstractforSystematic literature review and network meta-analysis of pembrolizumab versus other interventions for previously untreated, unresectable or metastatic, MSI-high or MMR-deficient CRC | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 437 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancer
David M O'Malley et al.
Method | Published online: 31 Jul 2024
Open Access
Health-related quality of life in patients with Waldenström macroglobulinemia: results from the ASPEN trial
Alessandra Tedeschi et al.
Rapid Communication | Published online: 29 Jul 2024
Open Access
Quality of life in cemiplimab-treated patients with locally advanced basal cell carcinoma in a Phase II clinical trial
Alexander J Stratigos et al.
Rapid Communication | Published online: 29 Jul 2024
Open Access
Transfusion-related cost offsets and time burden in patients with myelofibrosis on momelotinib vs. danazol from MOMENTUM
Lucia Masarova et al.
Rapid Communication | Published online: 29 Jul 2024
Open Access
View all latest articles